BioSymetrics
Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist to add human cellular phenotyping to its Parkinson's disease discovery and validation platform. Under the deal, Lunai gains exclusive rights to Tanaist's licensed…
Impact: BioSymetrics, Lunai's wholly owned subsidiary, operates the Augusta AI platform that identified the Parkinson's subtypes central to the collaboration. Its computational findings will be tested against Tanaist's cellular biology, potentially strengthening its scientific standing.
Sep 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track BioSymetrics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard